company background image
APTA logo

Aptamer Group AIM:APTA Stock Report

Last Price

UK£0.0063

Market Cap

UK£2.9m

7D

-7.4%

1Y

-97.9%

Updated

25 Mar, 2024

Data

Company Financials

APTA Stock Overview

Aptamer Group plc provides binders for research, diagnostics, and therapeutics in the United Kingdom, rest of Europe, and internationally.

APTA fundamental analysis
Snowflake Score
Valuation2/6
Future Growth0/6
Past Performance0/6
Financial Health2/6
Dividends0/6

Aptamer Group plc Competitors

Price History & Performance

Summary of all time highs, changes and price drops for Aptamer Group
Historical stock prices
Current Share PriceUK£0.0063
52 Week HighUK£0.31
52 Week LowUK£0.0055
Beta-0.40
1 Month Change-7.41%
3 Month Change-46.81%
1 Year Change-97.88%
3 Year Changen/a
5 Year Changen/a
Change since IPO-99.56%

Recent News & Updates

Recent updates

We're Hopeful That Aptamer Group (LON:APTA) Will Use Its Cash Wisely

Mar 15
We're Hopeful That Aptamer Group (LON:APTA) Will Use Its Cash Wisely

Shareholder Returns

APTAGB BiotechsGB Market
7D-7.4%2.1%2.1%
1Y-97.9%-29.8%3.8%

Return vs Industry: APTA underperformed the UK Biotechs industry which returned -27.1% over the past year.

Return vs Market: APTA underperformed the UK Market which returned 4.2% over the past year.

Price Volatility

Is APTA's price volatile compared to industry and market?
APTA volatility
APTA Average Weekly Movement14.8%
Biotechs Industry Average Movement7.8%
Market Average Movement4.8%
10% most volatile stocks in GB Market11.2%
10% least volatile stocks in GB Market2.5%

Stable Share Price: APTA's share price has been volatile over the past 3 months.

Volatility Over Time: APTA's weekly volatility has decreased from 23% to 15% over the past year, but is still higher than 75% of UK stocks.

About the Company

FoundedEmployeesCEOWebsite
200846n/ahttps://aptamergroup.com

Aptamer Group plc provides binders for research, diagnostics, and therapeutics in the United Kingdom, rest of Europe, and internationally. The company offers Optimer platform that enables the discovery and development of oligonucleotide binders; custom development services for oligonucleotide-based aptamer and Optimer binders; solutions to bioprocessing, diagnostic, and pharmaceutical scientists; and contract research services in the field of therapeutics. It serves pharma companies, diagnostic development companies, and research institutes.

Aptamer Group plc Fundamentals Summary

How do Aptamer Group's earnings and revenue compare to its market cap?
APTA fundamental statistics
Market capUK£2.92m
Earnings (TTM)-UK£7.84m
Revenue (TTM)UK£1.75m

1.7x

P/S Ratio

-0.4x

P/E Ratio

Earnings & Revenue

Key profitability statistics from the latest earnings report (TTM)
APTA income statement (TTM)
RevenueUK£1.75m
Cost of RevenueUK£1.39m
Gross ProfitUK£359.00k
Other ExpensesUK£8.20m
Earnings-UK£7.84m

Last Reported Earnings

Jun 30, 2023

Next Earnings Date

Mar 28, 2024

Earnings per share (EPS)-0.017
Gross Margin20.49%
Net Profit Margin-447.26%
Debt/Equity Ratio22.7%

How did APTA perform over the long term?

See historical performance and comparison
Simply Wall Street Pty Ltd (ACN 600 056 611), is a Corporate Authorised Representative (Authorised Representative Number: 467183) of Sanlam Private Wealth Pty Ltd (AFSL No. 337927). Any advice contained in this website is general advice only and has been prepared without considering your objectives, financial situation or needs. You should not rely on any advice and/or information contained in this website and before making any investment decision we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice. Please read our Financial Services Guide before deciding whether to obtain financial services from us.